Bik promotes proteasomal degradation to control low-grade inflammation

Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Journal of clinical investigation Ročník 134; číslo 4
Hlavní autoři: Mebratu, Yohannes A., Jones, Jane T., Liu, Congjian, Negasi, Zerihun H., Rahman, Mizanur, Rojas-Quintero, Joselyn, O’Connor, George T., Gao, Wei, Dupuis, Josée, Cho, Michael H., Litonjua, Augusto A., Randell, Scott, Tesfaigzi, Yohannes
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States American Society for Clinical Investigation 15.02.2024
Témata:
Allergic reaction
Allergy
Animals
Apoptosis
Apoptosis Regulatory Proteins
Apoptotic proteins
Autoimmunity
Development and progression
Diseases
Emphysema
Emphysema, Pulmonary
Female
Genetic aspects
Genetic engineering
Health aspects
Heart diseases
Hexosyltransferases
Humans
Inflammation
Inflammation - genetics
Male
Massachusetts
Mice
Mitochondrial Proteins
New Mexico
Nuclear Proteins
Physiological aspects
Proteasome Endopeptidase Complex - genetics
Proteins
Proteolysis
Proto-Oncogene Proteins c-bcl-2
Single nucleotide polymorphisms
Tetracycline
Tetracyclines
United States
New Mexico
Massachusetts
Inflammation
NF-kappaB
Peptides
Apoptosis
ISSN:1558-8238, 0021-9738, 1558-8238
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2-interacting killer (Bik) deficiency causes low-level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of Bik-deficient mice inhibited allergen- or LPS-induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases.
AbstractList Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2-interacting killer (Bik) deficiency causes low-level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of Bik-deficient mice inhibited allergen- or LPS-induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases.
Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2-interacting killer (Bik) deficiency causes low- level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of B/'/c- deficient mice inhibited allergen- or LPS- induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases.
Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2-interacting killer (Bik) deficiency causes low-level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of Bik-deficient mice inhibited allergen- or LPS-induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases.Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2-interacting killer (Bik) deficiency causes low-level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of Bik-deficient mice inhibited allergen- or LPS-induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases.
Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage to organ systems and thereby contribute to age-related disorders, such as respiratory disorders, heart disease, metabolic disorders, autoimmunity, and cancer. However, the molecular mechanisms governing low-level inflammation are largely unknown. We discovered that Bcl-2–interacting killer (Bik) deficiency causes low-level inflammation even at baseline and the development of spontaneous emphysema in female but not male mice. Similarly, a single nucleotide polymorphism that reduced Bik levels was associated with increased inflammation and enhanced decline in lung function in humans. Transgenic expression of Bik in the airways of Bik-deficient mice inhibited allergen- or LPS-induced lung inflammation and reversed emphysema in female mice. Bik deficiency increased nuclear but not cytosolic p65 levels because Bik, by modifying the BH4 domain of Bcl-2, interacted with regulatory particle non-ATPase 1 (RPN1) and RPN2 and enhanced proteasomal degradation of nuclear proteins. Bik deficiency increased inflammation primarily in females because Bcl-2 and Bik levels were reduced in lung tissues and airway cells of female compared with male mice. Therefore, controlling low-grade inflammation by modifying the unappreciated role of Bik and Bcl-2 in facilitating proteasomal degradation of nuclear proteins may be crucial in treating chronic age-related diseases. The cell death regulatory Bik binds to nuclear Bcl-2 to modify protein stability and inflammation.
Audience Academic
Author O’Connor, George T.
Rojas-Quintero, Joselyn
Tesfaigzi, Yohannes
Gao, Wei
Negasi, Zerihun H.
Mebratu, Yohannes A.
Jones, Jane T.
Rahman, Mizanur
Randell, Scott
Liu, Congjian
Dupuis, Josée
Cho, Michael H.
Litonjua, Augusto A.
AuthorAffiliation 2 University Geisel School of Medicine, Department of Microbiology and Immunology, Dartmouth, Hanover, New Hampshire, USA
8 Division of Pediatric Pulmonary Medicine, University of Rochester Medical Center, Rochester, New York, USA
1 Brigham and Women’s Hospital, Division of Pulmonary and Critical Medicine, Harvard Medical School, Boston, Massachusetts, USA
4 National Heart, Lung, and Blood Institute’s (NHLBI’s) Framingham Heart Study, Framingham, Massachusetts, USA
3 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts, USA
6 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
7 Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
9 Marsico Lung Institute, UNC School of Medicine, Chapel Hill, North Carolina, USA
5 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA
AuthorAffiliation_xml – name: 7 Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
– name: 2 University Geisel School of Medicine, Department of Microbiology and Immunology, Dartmouth, Hanover, New Hampshire, USA
– name: 6 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
– name: 3 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts, USA
– name: 5 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA
– name: 4 National Heart, Lung, and Blood Institute’s (NHLBI’s) Framingham Heart Study, Framingham, Massachusetts, USA
– name: 9 Marsico Lung Institute, UNC School of Medicine, Chapel Hill, North Carolina, USA
– name: 8 Division of Pediatric Pulmonary Medicine, University of Rochester Medical Center, Rochester, New York, USA
– name: 1 Brigham and Women’s Hospital, Division of Pulmonary and Critical Medicine, Harvard Medical School, Boston, Massachusetts, USA
Author_xml – sequence: 1
  givenname: Yohannes A.
  surname: Mebratu
  fullname: Mebratu, Yohannes A.
– sequence: 2
  givenname: Jane T.
  surname: Jones
  fullname: Jones, Jane T.
– sequence: 3
  givenname: Congjian
  surname: Liu
  fullname: Liu, Congjian
– sequence: 4
  givenname: Zerihun H.
  surname: Negasi
  fullname: Negasi, Zerihun H.
– sequence: 5
  givenname: Mizanur
  surname: Rahman
  fullname: Rahman, Mizanur
– sequence: 6
  givenname: Joselyn
  surname: Rojas-Quintero
  fullname: Rojas-Quintero, Joselyn
– sequence: 7
  givenname: George T.
  surname: O’Connor
  fullname: O’Connor, George T.
– sequence: 8
  givenname: Wei
  orcidid: 0000-0002-4088-3210
  surname: Gao
  fullname: Gao, Wei
– sequence: 9
  givenname: Josée
  surname: Dupuis
  fullname: Dupuis, Josée
– sequence: 10
  givenname: Michael H.
  orcidid: 0000-0002-4907-1657
  surname: Cho
  fullname: Cho, Michael H.
– sequence: 11
  givenname: Augusto A.
  orcidid: 0000-0003-0422-5875
  surname: Litonjua
  fullname: Litonjua, Augusto A.
– sequence: 12
  givenname: Scott
  orcidid: 0000-0001-5351-2841
  surname: Randell
  fullname: Randell, Scott
– sequence: 13
  givenname: Yohannes
  orcidid: 0000-0002-3997-5839
  surname: Tesfaigzi
  fullname: Tesfaigzi, Yohannes
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38113109$$D View this record in MEDLINE/PubMed
BookMark eNqNkklv1DAYhiNURBc48AdQJCQEh7R24i2nqowoDKpUie1qObaTcXHiwXZY_j3OTBkmaA7IB1v2873-lvc0OxrcoLPsKQTnENLy4v1iCSnANXqQnUCMWcHKih3tnY-z0xDuAIAIYfQoO64YhBUE9Ul2_dp8zdfe9S7qMB2iFsH1wuZKd14oEY0b8uhy6Ybonc2t-1FMDzo3Q2tF32-Ix9nDVtign9zvZ9nn6zefFu-Km9u3y8XVTSEJIrEQtGSaYlADWTJSKlaDppUUqIpKpVhZAsFaqktKiYAlILhFjJBWsgajSiJdnWXLra5y4o6vvemF_8WdMHxz4XzHhY9GWs2pquqWVojUDCHSVA2eKm4VqoVqoMBJ63KrtR6bXiupU4HCzkTnL4NZ8c595xCkpAhmSeHlvYJ330YdIu9NkNpaMWg3Bl7WAEFM0gQS-nyLdiLlllrnkqSccH5FGQGkqlGdqOIA1elBp__TzFuTrmf8-QE-LaV7Iw8GvJoFTFPVP2MnxhD48uOH_2dvv8zZF3vsSgsbV8HZcfJGmIPP9pu-6_YfR_79VXoXgtftDoGAT27nO7cn9uIfVpq48WNqg7EHIn4D46n7oA
CitedBy_id crossref_primary_10_1073_pnas_2424367122
crossref_primary_10_1186_s12931_024_02978_w
crossref_primary_10_1177_10445498251379681
crossref_primary_10_1172_JCI177753
crossref_primary_10_3389_fphar_2025_1559546
Cites_doi 10.1016/j.cell.2009.04.061
10.1084/jem.20040196
10.1093/ajcp/106.5.652
10.1128/MCB.24.4.1570-1581.2004
10.4049/jimmunol.173.11.7003
10.1083/jcb.201901156
10.3389/fcell.2018.00013
10.1152/ajplung.00174.2007
10.1038/365182a0
10.1093/toxsci/kfl016
10.1038/mi.2017.117
10.1038/s41569-018-0064-2
10.1038/s41598-018-30602-7
10.1093/geront/6.4.179
10.1038/43466
10.1164/rccm.201011-1930OC
10.1172/JCI10259
10.3109/15412550903499522
10.1503/cmaj.122072
10.1038/s41590-020-0622-8
10.1073/pnas.0705316104
10.1183/09031936.00063112
10.1164/ajrccm.158.5.9706116
10.18632/aging.100531
10.1056/NEJMoa1411532
10.1074/jbc.M407659200
10.1074/jbc.273.14.7783
10.1159/000072965
10.1017/S0007114511005460
10.1183/09031936.97.10040822
10.1038/sj.emboj.7600592
10.1038/ncb894
10.1074/jbc.C400442200
10.1164/rccm.201511-2219OC
10.1152/physrev.00025.2015
10.1146/annurev.med.51.1.245
10.1016/j.molcel.2008.06.014
10.1016/0002-8703(83)90532-X
10.1111/j.1600-065X.2012.01098.x
10.1038/nature06924
10.1016/j.immuni.2014.09.015
10.1126/science.1136678
10.4049/jimmunol.1302552
10.1002/jcp.30630
10.1083/jcb.200801186
10.1038/nature04870
10.1128/MCB.16.10.5857
10.1074/jbc.M606181200
10.1056/NEJMoa032158
10.1016/j.ypmed.2004.12.006
10.1038/s41467-019-13906-8
10.1183/09031936.00067008
10.1046/j.1471-4159.2003.02092.x
10.1016/j.jaci.2017.05.038
10.4161/cc.4.4.1587
10.2190/GGVP-XLB5-PC3N-EF0G
10.1080/08958378.2017.1311389
10.1073/pnas.95.6.2956
10.1016/j.cell.2009.05.005
10.1002/path.1711770305
10.1073/pnas.97.11.5723
10.1046/j.1365-3083.2003.01269.x
10.1080/1044667021000003989
10.1038/nature09982
10.1172/JCI2517
10.1038/s41467-017-00975-w
10.3389/fimmu.2021.708186
10.4049/jimmunol.170.12.6257
10.4049/jimmunol.1301329
10.1126/science.aad9421
10.1172/JCI88884
10.1038/nri1703
10.1056/NEJMoa1106955
10.1164/rccm.200507-1057OC
10.1038/ncomms6567
10.1056/NEJMoa1105482
10.1158/0008-5472.CAN-07-5836
10.1038/nature03491
ContentType Journal Article
Copyright COPYRIGHT 2024 American Society for Clinical Investigation
2023 Mebratu et al. 2023 Mebratu et al.
Copyright_xml – notice: COPYRIGHT 2024 American Society for Clinical Investigation
– notice: 2023 Mebratu et al. 2023 Mebratu et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
7X8
5PM
DOA
DOI 10.1172/JCI170594
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
ExternalDocumentID oai_doaj_org_article_7d39f734698446b3b53109fd49adb1a5
PMC10866658
A786063949
38113109
10_1172_JCI170594
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
New Mexico
Massachusetts
GeographicLocations_xml – name: United States
– name: New Mexico
– name: Massachusetts
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL140839
– fundername: NHLBI NIH HHS
  grantid: 75N92019D00031
– fundername: NHLBI NIH HHS
  grantid: N01 HC025195
– fundername: NIAID NIH HHS
  grantid: R01 AI148180
– fundername: NHLBI NIH HHS
  grantid: R01 HL068111
– fundername: NHLBI NIH HHS
  grantid: HHSN268201500001I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201500001C
– fundername: NIEHS NIH HHS
  grantid: P30 ES001247
– fundername: NIDDK NIH HHS
  grantid: P30 DK065988
– fundername: ;
  grantid: RO1HL068111
– fundername: ;
  grantid: RO1HL068111,R01HL140839
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
AAYXX
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
ADPDF
AEAQA
AENEX
AFCHL
AFFHD
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
EMB
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
CGR
CUY
CVF
ECM
EIF
NPM
PUEGO
ALIPV
7X8
5PM
ID FETCH-LOGICAL-c646t-a728e75090c2862d890bfc70d37cdd8220a8f7e2776a12065f4866fc8b543c4e3
IEDL.DBID DOA
ISICitedReferencesCount 4
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001178388500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1558-8238
0021-9738
IngestDate Fri Oct 03 12:50:40 EDT 2025
Tue Nov 04 02:05:48 EST 2025
Sun Aug 24 03:49:44 EDT 2025
Sat Nov 29 14:09:06 EST 2025
Sat Nov 29 12:13:19 EST 2025
Sat Nov 29 10:41:20 EST 2025
Wed Nov 26 11:23:01 EST 2025
Wed Nov 26 11:08:49 EST 2025
Thu May 22 21:25:34 EDT 2025
Fri Sep 19 01:51:00 EDT 2025
Sat Nov 29 03:10:15 EST 2025
Tue Nov 18 21:04:17 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Inflammation
NF-kappaB
Peptides
Apoptosis
Language English
License http://creativecommons.org/licenses/by/4.0
This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c646t-a728e75090c2862d890bfc70d37cdd8220a8f7e2776a12065f4866fc8b543c4e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authorship note: YAM and JTJ contributed equally to this work.
ORCID 0000-0001-5351-2841
0000-0002-3997-5839
0000-0002-4907-1657
0000-0003-0422-5875
0000-0002-4088-3210
OpenAccessLink https://doaj.org/article/7d39f734698446b3b53109fd49adb1a5
PMID 38113109
PQID 2904156823
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_7d39f734698446b3b53109fd49adb1a5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10866658
proquest_miscellaneous_2904156823
gale_infotracmisc_A786063949
gale_infotracgeneralonefile_A786063949
gale_infotracacademiconefile_A786063949
gale_incontextgauss_ISR_A786063949
gale_incontextgauss_IOV_A786063949
gale_healthsolutions_A786063949
pubmed_primary_38113109
crossref_primary_10_1172_JCI170594
crossref_citationtrail_10_1172_JCI170594
PublicationCentury 2000
PublicationDate 2024-02-15
PublicationDateYYYYMMDD 2024-02-15
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2024
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B64
B21
B65
B22
B66
B23
B67
B24
B68
B25
B69
B26
B27
B28
B29
Krajewski (B47) 1993; 53
B70
B71
B72
B73
B30
B74
B31
B75
B32
B76
B33
B77
B34
B78
B35
B79
B36
B37
B38
B39
B1
B2
B3
B4
B5
B6
B7
B8
B9
B80
B40
B41
B42
B43
B44
B45
B46
B49
B50
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
B16
B17
B18
B19
B60
B61
B62
Akao (B48) 1994; 54
B63
References_xml – ident: B65
  doi: 10.1016/j.cell.2009.04.061
– ident: B60
  doi: 10.1084/jem.20040196
– ident: B54
  doi: 10.1093/ajcp/106.5.652
– ident: B25
  doi: 10.1128/MCB.24.4.1570-1581.2004
– ident: B41
  doi: 10.4049/jimmunol.173.11.7003
– ident: B46
  doi: 10.1083/jcb.201901156
– ident: B49
  doi: 10.3389/fcell.2018.00013
– ident: B69
  doi: 10.1152/ajplung.00174.2007
– ident: B9
  doi: 10.1038/365182a0
– ident: B70
  doi: 10.1093/toxsci/kfl016
– ident: B17
  doi: 10.1038/mi.2017.117
– ident: B4
  doi: 10.1038/s41569-018-0064-2
– volume: 54
  start-page: 2468
  issue: 9
  year: 1994
  ident: B48
  article-title: Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes
  publication-title: Cancer Res
– ident: B78
  doi: 10.1038/s41598-018-30602-7
– ident: B33
  doi: 10.1093/geront/6.4.179
– ident: B39
  doi: 10.1038/43466
– ident: B21
  doi: 10.1164/rccm.201011-1930OC
– ident: B26
  doi: 10.1172/JCI10259
– ident: B36
  doi: 10.3109/15412550903499522
– ident: B5
  doi: 10.1503/cmaj.122072
– ident: B31
  doi: 10.1038/s41590-020-0622-8
– ident: B12
  doi: 10.1073/pnas.0705316104
– ident: B14
  doi: 10.1183/09031936.00063112
– ident: B13
  doi: 10.1164/ajrccm.158.5.9706116
– ident: B6
  doi: 10.18632/aging.100531
– ident: B32
  doi: 10.1056/NEJMoa1411532
– ident: B59
  doi: 10.1074/jbc.M407659200
– ident: B23
  doi: 10.1074/jbc.273.14.7783
– ident: B76
  doi: 10.1159/000072965
– ident: B3
  doi: 10.1017/S0007114511005460
– ident: B74
  doi: 10.1183/09031936.97.10040822
– ident: B43
  doi: 10.1038/sj.emboj.7600592
– ident: B56
  doi: 10.1038/ncb894
– ident: B68
  doi: 10.1074/jbc.C400442200
– ident: B28
  doi: 10.1164/rccm.201511-2219OC
– ident: B29
  doi: 10.1152/physrev.00025.2015
– ident: B7
  doi: 10.1146/annurev.med.51.1.245
– ident: B50
  doi: 10.1016/j.molcel.2008.06.014
– ident: B34
  doi: 10.1016/0002-8703(83)90532-X
– ident: B15
  doi: 10.1111/j.1600-065X.2012.01098.x
– ident: B63
  doi: 10.1038/nature06924
– ident: B8
  doi: 10.1016/j.immuni.2014.09.015
– ident: B30
  doi: 10.1126/science.1136678
– ident: B67
  doi: 10.4049/jimmunol.1302552
– ident: B44
  doi: 10.1002/jcp.30630
– ident: B20
  doi: 10.1083/jcb.200801186
– ident: B40
  doi: 10.1038/nature04870
– ident: B19
  doi: 10.1128/MCB.16.10.5857
– ident: B57
  doi: 10.1074/jbc.M606181200
– ident: B79
  doi: 10.1056/NEJMoa032158
– ident: B73
  doi: 10.1016/j.ypmed.2004.12.006
– ident: B62
  doi: 10.1038/s41467-019-13906-8
– ident: B77
  doi: 10.1183/09031936.00067008
– ident: B52
  doi: 10.1046/j.1471-4159.2003.02092.x
– ident: B22
  doi: 10.1016/j.jaci.2017.05.038
– ident: B55
  doi: 10.4161/cc.4.4.1587
– ident: B37
  doi: 10.2190/GGVP-XLB5-PC3N-EF0G
– ident: B38
  doi: 10.1080/08958378.2017.1311389
– ident: B58
  doi: 10.1073/pnas.95.6.2956
– ident: B66
  doi: 10.1016/j.cell.2009.05.005
– ident: B53
  doi: 10.1002/path.1711770305
– ident: B51
  doi: 10.1073/pnas.97.11.5723
– ident: B72
  doi: 10.1046/j.1365-3083.2003.01269.x
– ident: B71
  doi: 10.1080/1044667021000003989
– ident: B16
  doi: 10.1038/nature09982
– ident: B18
  doi: 10.1172/JCI2517
– ident: B24
  doi: 10.1038/s41467-017-00975-w
– ident: B1
  doi: 10.3389/fimmu.2021.708186
– ident: B42
  doi: 10.4049/jimmunol.170.12.6257
– ident: B11
  doi: 10.4049/jimmunol.1301329
– ident: B64
  doi: 10.1126/science.aad9421
– ident: B2
  doi: 10.1172/JCI88884
– ident: B10
  doi: 10.1038/nri1703
– ident: B27
  doi: 10.1056/NEJMoa1106955
– ident: B75
  doi: 10.1164/rccm.200507-1057OC
– ident: B80
  doi: 10.1038/ncomms6567
– ident: B35
  doi: 10.1056/NEJMoa1105482
– ident: B45
  doi: 10.1158/0008-5472.CAN-07-5836
– volume: 53
  start-page: 4701
  issue: 19
  year: 1993
  ident: B47
  article-title: Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
  publication-title: Cancer Res
– ident: B61
  doi: 10.1038/nature03491
SSID ssj0014454
Score 2.4727466
Snippet Although chronic low-grade inflammation does not cause immediate clinical symptoms, over the longer term, it can enhance other insults or age-dependent damage...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Allergic reaction
Allergy
Animals
Apoptosis
Apoptosis Regulatory Proteins
Apoptotic proteins
Autoimmunity
Development and progression
Diseases
Emphysema
Emphysema, Pulmonary
Female
Genetic aspects
Genetic engineering
Health aspects
Heart diseases
Hexosyltransferases
Humans
Inflammation
Inflammation - genetics
Male
Massachusetts
Mice
Mitochondrial Proteins
New Mexico
Nuclear Proteins
Physiological aspects
Proteasome Endopeptidase Complex - genetics
Proteins
Proteolysis
Proto-Oncogene Proteins c-bcl-2
Single nucleotide polymorphisms
Tetracycline
Tetracyclines
Title Bik promotes proteasomal degradation to control low-grade inflammation
URI https://www.ncbi.nlm.nih.gov/pubmed/38113109
https://www.proquest.com/docview/2904156823
https://pubmed.ncbi.nlm.nih.gov/PMC10866658
https://doaj.org/article/7d39f734698446b3b53109fd49adb1a5
Volume 134
WOSCitedRecordID wos001178388500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: DOA
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: M7P
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: 7X7
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: 7RV
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: BENPR
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELVgQYgL4pvAUgJCwCXaJnH8cdyutmKRKFWBVW-R4zhLxZKsNi38fWZsN6rFSnDgkkP9KiUz48yM8vyGkNdSGCgDVJ1ozgpoUCoKWwopUFD6y7Rq2Fi7YRN8NhPLpZzvjPpCTpiTB3aGO-B1Lhue46BD6FyqvCpQy7KpqVR1lSqrXgpVz7aZ8t8PKC2o1xGCDH3w4egEZWMkDbKPFen_81W8k4tCnuRO4pneJXd8xRgfuju9R66Z9j659dF_E39AppPV9_jCsupMH1vdBdV3P-AvNQpBuJlJ8bqLPSs9Pu9-JbhgYoguCAh3ePEh-To9_nL0PvHTERLNKFsnimfCYL4f6wzaklrIcdVoPq5zrusa8v5YiYabjHOm0gwqjYYKxhotqoLmmpr8Edlru9Y8ITGTVQNtF7jMFKjAp3JWKS6UyFGqRdGIvNtardReOhwnWJyXtoXgWTkYOCKvBuiF08u4CjRB0w8AlLi2P4DjS-_48m-Oj8gLdFzpzosOG7U85IJh3UUl3ItFoMxFizyaM7Xp-_Lk0-k_gD4vAtBbD2o6eHCt_NkFMB_KZwXINwHyzImHXwXcD4Cwq3Ww_HIbjyUuIRWuNd2mLzOJqgpMZHlEHrv4HAwJ5VeKVoqICCI3sHS40q6-WVFxnLjFoBx9-j9884zczqD4Q3Z7WuyTvfXlxjwnN_XP9aq_HJHrfHGK1yW3VzEiNybHs_liZDfxCPm389-fy0Xg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bik+promotes+proteasomal+degradation+to+control+low-grade+inflammation&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Mebratu%2C+Yohannes+A&rft.au=Jones%2C+Jane+T&rft.au=Liu%2C+Congjian&rft.au=Negasi%2C+Zerihun+H&rft.date=2024-02-15&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=134&rft.issue=4&rft_id=info:doi/10.1172%2FJCI170594&rft.externalDocID=A786063949
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-8238&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-8238&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-8238&client=summon